Cargando…
Charcoal Hemoperfusion for Methotrexate Toxicity: A Safe and Effective Life-Rescue Alternative When Glucarpidase Is Not Available
Background: High dose methotrexate (HDMTX) is used for the treatment of pediatric hemato-oncological diseases. HDMTX can induce acute kidney injury in cases of delayed elimination. The use of leucovorin remains the most effective rescue action. Further treatment options are of difficult access in th...
Autores principales: | Rosales, Alejandra, Madrid, Alvaro, Muñoz, Marina, Dapena, Jose Luis, Ariceta, Gema |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8417363/ https://www.ncbi.nlm.nih.gov/pubmed/34490152 http://dx.doi.org/10.3389/fped.2021.635152 |
Ejemplares similares
-
High-dose continuous venovenous hemofiltration combined with charcoal hemoperfusion for methotrexate removal
por: Grafft, Carrie, et al.
Publicado: (2011) -
Glucarpidase to combat toxic levels of methotrexate in patients
por: Green, Jacalyn M
Publicado: (2012) -
Half-dose glucarpidase as efficient rescue for toxic methotrexate levels in patients with acute kidney injury
por: Heuschkel, Sandra, et al.
Publicado: (2021) -
Charcoal Hemoperfusion in Calcium Channel Antagonist Poisoning
por: Kocoğlu Barlas, Ülkem, et al.
Publicado: (2023) -
Development of a population pharmacokinetics and pharmacodynamics model of glucarpidase rescue treatment after high-dose methotrexate therapy
por: Fukaya, Yutaka, et al.
Publicado: (2023)